Corvus Pharmaceuticals: The Market Likes The Story

Core Insights - The discussion in the biotech community has focused on profitable buy-write or covered call strategies on selected biotech stocks in recent months [1]. Company Spotlight - Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) has experienced a significant increase in its share price recently, raising questions about the sustainability of this rally and the potential for profit-taking [2]. - The investing group, The Biotech Forum, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat discussions and weekly research updates [2].